NCT07438639

Brief Summary

This study aims to test the effectiveness of virtual reality-supported speech therapy in improving basic language skills in children aged 3 to 6 years diagnosed with Developmental Language Disorder (DLD). Participants are randomly assigned to either traditional speech therapy or virtual reality-supported therapy, with the same frequency and duration of intervention. Language outcomes are assessed before and after treatment using the Language development level test (TVL), a standardized assessment of Italian for preschoolers. The study adopts a randomized controlled design with individualized, goal-oriented therapy delivered by certified speech-language pathologists.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Feb 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Feb 2023Dec 2026

Study Start

First participant enrolled

February 1, 2023

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

February 16, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

3.8 years

First QC Date

February 16, 2026

Last Update Submit

February 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Language Development Level Test (TVL)

    The Test of Verbalization and Language Development is a standardized tool designed to assess various aspects of language development, including verbal production, comprehension, sentence construction, phonological accuracy, and morphosyntactic abilities. The weighted score ranges from 0 to 10, with higher scores indicating better language development.

    Baseline and Month 3

Secondary Outcomes (1)

  • Griffiths III Scales

    Baseline

Study Arms (2)

VR-Supported Speech Therapy

EXPERIMENTAL

Children receive two 60-minute sessions per week for six months using the Virtual Reality Rehabilitation System (VRRS).

Device: Virtual Reality Rehabilitation System (VRRS)

Traditional Speech Therapy

ACTIVE COMPARATOR

Children receive the same therapy schedule and goals through conventional speech-language sessions using printed materials, games, and verbal interaction.

Behavioral: Taditional Speech Therapy

Interventions

The VRRS delivers personalized language therapy exercises via touchscreen interface. Activities target receptive language, repetition, naming, and spontaneous language production. All sessions are conducted by trained speech-language pathologists in accordance with standardized therapeutic protocols.

VR-Supported Speech Therapy

Standard speech-language therapy delivered in-person by certified therapists, targeting the same language domains with paper-based and interactive materials.

Traditional Speech Therapy

Eligibility Criteria

Age3 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 3 and 6 years at enrollment
  • Clinical diagnosis of Developmental Language Disorder (DLD) based on DSM-5 and standardized language assessments
  • Developmental Quotient (DQ) \> 70 on the Griffiths III Scales
  • Good general health without neurological or psychiatric comorbidities
  • Informed consent signed by a parent or legal guardian

You may not qualify if:

  • Age not between 3 and 6 years
  • Lack of clinical diagnosis of Developmental Language Disorder (DLD)
  • Developmental Quotient (DQ) \< 70 on the Griffiths Scale III
  • Presence of neurological or psychiatric comorbidities
  • Lack of signed informed consent from a parent or legal guardian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Francesca Cucinotta

Messina, Italy

Location

Related Publications (2)

  • Cappadona I, Ielo A, La Fauci M, Tresoldi M, Settimo C, De Cola MC, Muratore R, De Domenico C, Di Cara M, Corallo F, Tripodi E, Impallomeni C, Quartarone A, Cucinotta F. Feasibility and Effectiveness of Speech Intervention Implemented with a Virtual Reality System in Children with Developmental Language Disorders: A Pilot Randomized Control Trial. Children (Basel). 2023 Aug 1;10(8):1336. doi: 10.3390/children10081336.

    PMID: 37628335BACKGROUND
  • van Vuuren S, Cherney LR. A Virtual Therapist for Speech and Language Therapy. Intell Virtual Agents. 2014 Jan 1;8637:438-448. doi: 10.1007/978-3-319-09767-1_55.

    PMID: 25938137BACKGROUND

MeSH Terms

Conditions

Language Development Disorders

Condition Hierarchy (Ancestors)

Language DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 27, 2026

Study Start

February 1, 2023

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations